Literature DB >> 7829622

Dose-response relationships for radiation-induced hyperparathyroidism.

A B Schneider1, T C Gierlowski, E Shore-Freedman, M Stovall, E Ron, J Lubin.   

Abstract

It has been hard to establish with certainty that radiation exposure is a risk factor for developing hyperparathyroidism. In part this is because many cases of hyperparathyroidism remain asymptomatic and escape clinical detection. We present results from a study of 2555 subjects who received external beam radiotherapy to the head and neck area for benign conditions before their 16th birthday between 1939 and 1962. The average length of follow-up was 36.6 yr. There were 36 confirmed cases of hyperparathyroidism. Based on a relative risk model, the excess relative risk increased significantly by 0.11/centigray; however, the confidence interval was wide (95% confidence interval, 0.0-17.2). The hyperparathyroidism rates and dose-response relationships were not affected by gender or age at first radiation treatment. The demonstration of a dose-response relationship within an irradiated cohort supports an association between radiation exposure and hyperparathyroidism and suggests that the calcium levels of individuals irradiated to the head and neck area should be monitored.

Entities:  

Mesh:

Year:  1995        PMID: 7829622     DOI: 10.1210/jcem.80.1.7829622

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  16 in total

1.  Hypercalcaemia in cancer.

Authors:  Simon Conroy; Brendan O'Malley
Journal:  BMJ       Date:  2005-10-22

Review 2.  Cytotoxic endocrinopathy: a legacy of insults.

Authors:  S M Shalet
Journal:  J R Soc Med       Date:  1997-04       Impact factor: 5.344

Review 3.  Clinical and molecular genetics of parathyroid neoplasms.

Authors:  John M Sharretts; William F Simonds
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2010-06       Impact factor: 4.690

Review 4.  Parathyroid cancer.

Authors:  John M Sharretts; Electron Kebebew; William F Simonds
Journal:  Semin Oncol       Date:  2010-12       Impact factor: 4.929

Review 5.  Hyperparathyroid genes: sequences reveal answers and questions.

Authors:  Stephen J Marx
Journal:  Endocr Pract       Date:  2011 Jul-Aug       Impact factor: 3.443

Review 6.  Hyperparathyroidism in the elderly patient.

Authors:  Rebecca Sims; Charanjeit Ubhi; David Hosking
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

7.  Primary hyperparathyroidism: Update on presentation, diagnosis, and management in primary care.

Authors:  Shelley Pallan; Aliya Khan
Journal:  Can Fam Physician       Date:  2011-02       Impact factor: 3.275

Review 8.  Multiplicity of hormone-secreting tumors: common themes about cause, expression, and management.

Authors:  Stephen J Marx
Journal:  J Clin Endocrinol Metab       Date:  2013-06-14       Impact factor: 5.958

9.  Acoustic neuromas following childhood radiation treatment for benign conditions of the head and neck.

Authors:  Arthur B Schneider; Elaine Ron; Jay Lubin; Marilyn Stovall; Eileen Shore-Freedman; Jocelyn Tolentino; Barbara J Collins
Journal:  Neuro Oncol       Date:  2007-12-13       Impact factor: 12.300

10.  131I treatment for thyroid cancer and risk of developing primary hyperparathyroidism: a cohort study.

Authors:  Chien-Mu Lin; Pat Doyle; Yu-Tse Tsan; Chang-Hsing Lee; Jung-Der Wang; Pau-Chung Chen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-08-28       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.